Primary hepatic and biliary tract tumors in dogs and cats: An overview - Veterinary Medicine
Medicine Center
DVM Veterinary Medicine Featuring Information from:


Primary hepatic and biliary tract tumors in dogs and cats: An overview
Since many of the clinical signs of hepatobiliary tumors are nonspecific, these tumors may be advanced at diagnosis. However, using the correct diagnostic tools, including cytology, tissue biopsy, and abdominal imaging, may lead to an earlier diagnosis and a better outcome.


14. Minkus G, Hillemanns M. Botryoid-type embryonal rhabdomyosarcoma of liver in a young cat. Vet Pathol 1997;34:618-621.

15. Dhaliwal RS, Johnson TO, Kitchell BE. Primary extraskeletal hepatic osteosarcoma in a cat. J Am Vet Med Assoc 2003;222:340-342, 316.

16. Strombeck DR. Clinicopathologic features of primary and metastatic neoplastic disease of the liver in dogs. J Am Vet Med Assoc 1978;173:267-269.

17. Evans SM. The radiographic appearance of primary liver neoplasia in dogs. Vet Radiol 1987;28:192-196.

18. Quigley KA, Jackson ML, Haines DM. Hyperlipasemia in 6 dogs with pancreatic or hepatic neoplasia: evidence for tumor lipase production. Vet Clin Pathol 2001;30:114-120.

19. Lowseth LA, Gillett NA, Chang IY, et al. Detection of serum alpha-fetoprotein in dogs with hepatic tumors. J Am Vet Med Assoc 1991;199:735-741.

20. Yamada T, Fujita M, Kitao S, et al. Serum alpha-fetoprotein values in dogs with various hepatic diseases. J Vet Med Sci 1999;61:657-659.

21. Kosovsky JE, Manfra-Marretta S, Matthiesen DT, et al. Results of partial hepatectomy in 18 dogs with hepatocellular carcinoma. J Am Anim Hosp Assoc 1989;25:203-206.

22. Liptak JM, Dernell WS, Monnet E, et al. Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002). J Am Vet Med Assoc 2004;225:1225-1230.

23. Ogilvie GK, Obradovich JE, Elmslie RE, et al. Efficacy of mitoxantrone against various neoplasms in the dog. J Am Vet Med Assoc 1991;198:1618-1621.

24. Moore AS, Kitchell BE. New chemotherapy agents in veterinary medicine. Vet Clin North Am Small Anim Pract 2003;33:629-649, viii. Review.

25. Shimada M, Takenaka K, Kawahara N, et al. Chemosensitivity in primary liver cancers: evaluation of the correlation between chemosensitivity and clinicopathological factors. Hepatogastroenterology 1996;43:1159-1164.

26. Weisse C, Clifford CA, Holt D, et al. Percutaneous arterial embolization and chemoembolization for treatment of benign and malignant tumors in three dogs and a goat. J Am Vet Med Assoc 2002;221:1430-1436, 1419.

27. Huang CC, Wu MC, Xu GW, et al. Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma. J Natl Cancer Inst 1992;84:262-264.

28. Park JG, Lee SK, Hong IG, et al. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. J Natl Cancer Inst 1994;86:700-705.

29. Patnaik AK, Hurvitz AI, Lieberman PH, et al. Canine hepatocellular carcinoma. Vet Pathol 1981;18:427-438.

30. Leifer CE, Peterson ME, Matus RE, et al. Hypoglycemia associated with nonislet cell tumor in 13 dogs. J Am Vet Med Assoc 1985;186:53-55.

31. Patnaik AK, Hurvitz AI, Lieberman PH, et al. Canine bile duct carcinoma. Vet Pathol 1981;18:439-444.

32. Strafuss AC. Bile duct carcinoma in dogs. J Am Vet Med Assoc 1976;169:429.

33. Hayes HM Jr, Morin MM, Rubenstein DA. Canine biliary carcinoma: epidemiological comparisons with man. J Comp Pathol 1983;93:99-107.

34. Chang HP. Hepatic clonorchiasis and carcinoma of the bile duct in a dog. J Pathol Bacteriol 1965;89:365-367.

35. Mehler SJ, Mayhew PD, Drobatz KJ, et al. Variables associated with outcome in dogs undergoing extrahepatic biliary surgery: 60 cases (1988-2002). Vet Surg 2004;33:644-649.

36. Patnaik AK, Lieberman PH, Hurvitz AI, et al. Canine hepatic carcinoids. Vet Pathol 1981;18:445-453.

37. Patnaik AK, Newman SJ, Scase T, et al. Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study. Vet Pathol 2005;42:140-146.

38. Lawrence HJ, Erb HN, Harvey HJ. Nonlymphomatous hepatobiliary masses in cats: 41 cases (1972 to 1991). Vet Surg 1994;23:365-368.

39. Patnaik AK. A morphologic and immunocytochemical study of hepatic neoplasms in cats. Vet Pathol 1992;29:405-415.

40. Post G, Patnaik AK. Nonhematopoietic hepatic neoplasms in cats: 21 cases (1983-1988). J Am Vet Med Assoc 1992;201:1080-1082.

41. Nyland TG, Koblik PD, Tellyer SE. Ultrasonographic evaluation of biliary cystadenomas in cats. Vet Radiol Ultrasound 1999;40:300-306.

42. Adler R, Wilson DW. Biliary cystadenoma of cats. Vet Pathol 1995;32:415-418.

43. Trout NJ. Surgical treatment of hepatobiliary cystadenomas in cats. Semin Vet Med Surg (Small Anim) 1997;12:51-53.

44. Trout NJ, Berg RJ, McMillan MC, et al. Surgical treatment of hepatobiliary cystadenomas in cats: five cases (1988-1993). J Am Vet Med Assoc 1995;206:505-507.

45. Patnaik AK, Lieberman PH, Erlandson RA, et al. Hepatobiliary neuroendocrine carcinoma in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases. Vet Pathol 2005;42:331-337.


Click here